Private Capital Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-38,042
Closed -$9.67M 98
2020
Q3
$9.67M Sell
38,042
-75
-0.2% -$18.6K 2.25% 13
2020
Q2
$8.99M Sell
38,117
-50
-0.1% -$11.4K 2.33% 14
2020
Q1
$7.74M Sell
38,167
-127
-0.3% -$27.7K 2.45% 16
2019
Q4
$9.23M Sell
38,294
-75
-0.2% -$16.5K 2.26% 17
2019
Q3
$7.42M Sell
38,369
-150
-0.4% -$28.8K 2.06% 21
2019
Q2
$7.1M Buy
38,519
+200
+0.5% +$35.8K 2.01% 21
2019
Q1
$7.28M Buy
38,319
+132
+0.3% +$25.2K 2.2% 20
2018
Q4
$7.43M Hold
38,187
2.67% 12
2018
Q3
$7.92M Buy
38,187
+878
+2% +$173K 2.19% 18
2018
Q2
$6.89M Buy
37,309
+934
+3% +$165K 2.16% 18
2018
Q1
$6.2M Buy
+36,375
New +$6.68M 2.07% 17
2017
Q3
Sell
-2,900
Closed -$499K 108
2017
Q2
$499K Buy
+2,900
New +$472K 0.16% 95

Other funds holding AMGN

Private Capital Advisors's AMGN Position: Q4 2020 in Review

Private Capital Advisors sold out of Amgen (AMGN) in Q4 2020, closing a stake of 38,042 shares — an estimated $9.67M sold.

Private Capital Advisors first reported a position in AMGN in Q2 2017 and held it in 12 quarters. The position peaked at $9.67M in Q3 2020. 2,218 funds tracked by Wall St. Rank hold AMGN as of Q4 2020.

  • Private Capital Advisors reported no remaining Amgen position as of Q4 2020 after selling out during the quarter.
  • Private Capital Advisors sold 38,042 Amgen shares in Q4 2020, an estimated $9.67M.
  • Private Capital Advisors first reported a position in Amgen in Q2 2017 and held it in 12 quarters.
  • Private Capital Advisors's Amgen position peaked at $9.67M in Q3 2020.
  • 2,218 funds tracked by Wall St. Rank held Amgen as of Q4 2020.

Based on Private Capital Advisors's 13F filing for Q4 2020, filed 15 Jan 2021.